CN109396457A - A kind of shape and the controllable nanogold particle and the preparation method and application thereof of size - Google Patents
A kind of shape and the controllable nanogold particle and the preparation method and application thereof of size Download PDFInfo
- Publication number
- CN109396457A CN109396457A CN201811482468.3A CN201811482468A CN109396457A CN 109396457 A CN109396457 A CN 109396457A CN 201811482468 A CN201811482468 A CN 201811482468A CN 109396457 A CN109396457 A CN 109396457A
- Authority
- CN
- China
- Prior art keywords
- solution
- shape
- final concentration
- preparation
- seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 37
- 239000002245 particle Substances 0.000 title claims abstract description 20
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 45
- 239000010931 gold Substances 0.000 claims abstract description 44
- 229910052737 gold Inorganic materials 0.000 claims abstract description 44
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 32
- 230000012010 growth Effects 0.000 claims abstract description 26
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 18
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 16
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 15
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 15
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000003384 imaging method Methods 0.000 claims abstract description 13
- 239000003381 stabilizer Substances 0.000 claims abstract description 11
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 10
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 10
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 10
- 238000007626 photothermal therapy Methods 0.000 claims abstract description 8
- 239000001509 sodium citrate Substances 0.000 claims abstract description 8
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 7
- 206010028980 Neoplasm Diseases 0.000 claims description 27
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 17
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 239000002105 nanoparticle Substances 0.000 claims description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 8
- 239000005457 ice water Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- 239000003093 cationic surfactant Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 96
- 229910004042 HAuCl4 Inorganic materials 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000003917 TEM image Methods 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000035040 seed growth Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- JAJIPIAHCFBEPI-UHFFFAOYSA-N 9,10-dioxoanthracene-1-sulfonic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2S(=O)(=O)O JAJIPIAHCFBEPI-UHFFFAOYSA-N 0.000 description 2
- 101710134784 Agnoprotein Proteins 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000002923 metal particle Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 2
- 238000001931 thermography Methods 0.000 description 2
- POZPMIFKBAEGSS-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;trihydrate Chemical compound O.O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O POZPMIFKBAEGSS-UHFFFAOYSA-K 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 241001181013 Lappula Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/225—Microparticles, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Acoustics & Sound (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Manufacturing & Machinery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses the controllable nanogold particles and the preparation method and application thereof of a kind of shape and size.Using seed mediated growth method synthesizing water-solubility, it is monodispersed, the gold nano grain of different-shape size, including spherical shape, it is rodlike, dumbbell shaped, bipyramid shape, cubic and branched structure it is starlike etc., the serial nano gold is with ascorbic acid, sodium borohydride or hydroquinone are as reducing agent, cetyl trimethylammonium bromide is as cationic surfactant and stabilizer, sodium citrate is as reducing agent and stabilizer, it can get various sizes of nanogold by changing seed solution, realize the finely regulating of nanogold pattern and partial size, high yield, high-purity, good aqueous solubility, no biotoxicity, purifying process is simple.It can be applied to the fields such as photoacoustic imaging, photo-thermal therapy, bio-sensing.
Description
Technical Field
The invention belongs to the technical field of nano material preparation, relates to tumor imaging, photothermal therapy and the like in the field of biomedicine, and particularly relates to a preparation method of a series of nano gold particles with different shapes and sizes.
Background
Cancer has become a leading enemy of human health. Conventional treatment modalities include chemotherapy, radiation therapy, surgical resection, and the like. However, due to the challenges of poor patient compliance during chemotherapy, high surgical recurrence probability, damage to normal cells by radiotherapy, and the like, novel and effective cancer treatment strategies need to be researched. Targeted therapy is an emerging class of therapies that has evolved gradually from the late 90 s of the 20 th century and has achieved significant effects in the treatment of certain types of cancer. The nanometer material is used as a drug or gene transmission carrier, has the advantages of improving the water solubility and stability of the drug, reducing the toxicity of the drug, enhancing the curative effect of the drug, improving the distribution of the drug in vivo and the like, and develops rapidly in recent years.
Today, nano-gold shows huge potential in the biomedical field by virtue of unique physicochemical property and optical property thereof, and research of nano-gold also gets very extensive attention. The nano gold is a gold material with the grain diameter of 1nm-250nm, is easy to synthesize, has small toxicity and good biocompatibility, can accurately regulate and control the optical property of the nano gold, and is easy to be used for modifying medicines and targeting molecules. As nano metal particles, surface electrons can only vibrate in a nano size, thus generating a local plasma phenomenon, and when near infrared light with a proper wavelength is used for irradiation, the metal particles can absorb light energy and convert the light energy into heat energy, namely, a photothermal effect. And the nano gold is used as inert metal, and in an excitation area, because of the enhancement of a near-surface electromagnetic field, a Raman scattering signal absorbed by molecules is greatly enhanced compared with that of common Raman scattering. By utilizing the Surface Enhanced Raman Scattering (SERS) and local plasmon resonance (LSPR) effects of the nanogold, the nanogold becomes a research hotspot of current tumor treatment and early disease diagnosis. At present, the preparation of the nano gold particles is divided into two strategies, namely a top-down physical method and a bottom-up chemical method. The seed growth method is the most common method at present, and can further grow the gold core into the gold nano-particles with specific size and shape.
In order to rapidly and efficiently obtain nanogold with different shapes and properties, which can be used in the fields of tumor diagnosis and treatment such as photothermal therapy, photoacoustic imaging and the like, a universal and environment-friendly preparation method of nanogold particles is developed to meet new research requirements.
Disclosure of Invention
In order to overcome the defects in the prior art, the invention aims to synthesize a series of gold nanoparticles with different shapes and sizes of 50nm or 100nm by using a seed growth method, and the obtained gold nanoparticles have better water solubility and monodispersity and good biocompatibility and can be used for tumor photothermal therapy and photoacoustic imaging.
In order to achieve the above purpose, the invention provides the following technical scheme:
in a first aspect, a method for preparing gold nanoparticles with controllable shape and size is provided, which comprises the following steps:
(1) preparation of seed solution: dissolving a proper amount of stabilizer in deionized water, adding chloroauric acid, stirring uniformly, then adding a sodium borohydride solution prepared by ice water or adopting a thermal reduction mode to form a brown yellow or red solution, and keeping the temperature of 25-110 ℃ for reaction;
(2) preparation of growth solution: a. dissolving a certain amount of stabilizer in deionized water, mixing with chloroauric acid solution, and changing the solution from dark yellow to colorless;
or,
a', dissolving a certain amount of stabilizer in deionized water, mixing with chloroauric acid solution, and then adding a structure directing agent, a pH regulator and a reducing agent to change the solution from dark yellow to colorless;
(3) mixing the seed solution obtained in the step (1) with the growth solution obtained in the step (2), and reacting in a water bath at 29-95 ℃;
or,
mixing the seed solution obtained in the step (1) with the growth solution obtained in the step (2) to prepare a new seed solution, mixing the new seed solution with the growth solution obtained in the step (2), and keeping the new seed solution in a water bath at 29-95 ℃ for reaction;
(4) and after the reaction is finished, collecting, centrifuging and purifying to obtain the nano gold particles.
Preferably, in the above preparation method, the stabilizer in step (1) and step (2) is cetyl trimethyl ammonium bromide or sodium citrate; the structure directing agent in the step (2) is silver nitrate or potassium iodide, the pH regulator is hydrochloric acid, and the reducing agent is ascorbic acid or hydroquinone.
Preferably, in the above preparation method, the final concentration of chloroauric acid is 0.01-0.025mol/L, the final concentration of sodium borohydride is 0.01-0.1mol/L, the final concentration of cetyltrimethylammonium bromide is 0.0001-0.1mol/L, the final concentration of silver nitrate is 0.004-0.01mol/L, the final concentration of potassium iodide is 0.01-0.1mol/L, the final concentration of hydroquinone is 0.01-0.06mol/L, the final concentration of ascorbic acid is 0.01-0.1mol/L, the final concentration of sodium citrate is 0.0022-0.02mol/L, and the final concentration of hydrochloric acid is 0.5-1.5 mol/L.
Preferably, in the above preparation method, the optimal seed reaction time in step (1) is 1-4h, and the optimal growth reaction time in step (3) is 12-16 h.
In a second aspect, the nano gold particles obtained by the preparation method are provided, the morphology of the nano gold particles is any one of spherical, cubic, star-shaped, rod-shaped, dumbbell and bipyramid, the particle size is 50nm or 100nm respectively, and the total number of the nano gold particles is 12.
The twelve types of nano gold particles prepared by the invention have obvious difference of maximum absorption peaks through UV/Vis wavelength scanning, the absorption peaks and colors show changes along with different shapes and sizes, and the maximum characteristic absorption peak of an ultraviolet-visible-infrared spectrum is positioned at 400-900 nm.
Zeta-potential results before and after centrifugal purification of the prepared gold nanoparticles show that after the centrifugal purification, after the excessive hexadecyl trimethyl ammonium bromide in the system is removed, potentials are reduced, but absolute values are still larger than 30mV, which shows that after the excessive hexadecyl trimethyl ammonium bromide in the system is removed by purification, the stability is good.
In a third aspect, the application of the gold nanoparticles in tumor photothermal therapy or tumor photoacoustic imaging is provided.
The present invention uses cetyl trimethyl ammonium bromide or sodium citrate as stabilizer, silver nitrate and potassium iodide as structure directing agent, ascorbic acid, sodium borohydride or hydroquinone as reducing agent, hydrochloric acid as pH regulator, and adopts two-step method to obtain a series of 50nm and 100nm star-shaped nano gold with spherical, rod-shaped, dumbbell-shaped, double cone-shaped, cubic and branched structures by changing the dosage of various compounds and the volume of the first-step seed solution.
Compared with the known method for synthesizing the nanogold material, the method has the advantages of simple and feasible preparation process, mild experimental conditions, cheap and easily-obtained required experimental reagents, effectively controlled morphology and size of the synthesized nanogold, good water solubility, good monodispersity, good stability, no toxic or side effect proved by in vitro experiments and good biocompatibility. Can be used for photothermal therapy, tumor imaging and the like.
Drawings
FIG. 1 shows the corresponding UV-Vis spectra of the nanogold solution with different morphologies of 50nm and 100nm in the embodiment.
FIG. 2 shows Zeta potentials before and after purification of 12 nanogold in a specific implementation method.
FIG. 3 shows transmission electron microscope images of 50nm and 100nm spherical nanogold described in example 1, wherein a is 50nm, b is 100 nm.
FIG. 4 shows transmission electron micrographs of 50nm and 100nm cubic nanogold as described in example 2, a, 50nm, b, and 100 nm.
FIG. 5 shows transmission electron micrographs of star-shaped 50nm and 100nm nanogold as described in example 3, a, 50nm, b, and 100 nm.
FIG. 6 is the transmission electron microscope pictures of the rod-shaped nanogold of 50nm and 100nm described in example 4, a, 50nm, b, and 100 nm.
FIG. 7 is a transmission electron micrograph of 50nm and 100nm dumbbell-shaped nanogold, a, 50nm, b, 100nm, described in example 5.
FIG. 8 is transmission electron microscope pictures of 50nm and 100nm bipyramidal nanogold described in example 6, a, 50nm, b, 100 nm.
Fig. 9 shows the actual particle size of nanogold through TEM in all examples.
FIG. 10 shows the toxic effect of six nanogold at 50nm on HepG2 and LO2 cells in all examples.
FIG. 11 shows the toxic effect of six nanogold at 100nm on HepG2 and LO2 cells in all examples.
Fig. 12 is a photo-thermal imaging diagram of 100nm bipyramid nanogold during tumor photo-thermal treatment.
Fig. 13 is a tumor ultrasonic-photoacoustic imaging picture of 100nm cubic nano-gold.
Detailed Description
The features and advantages of the present invention will be further understood from the following detailed description taken in conjunction with the accompanying drawings. The examples provided are merely illustrative of the method of the present invention and do not limit the remainder of the disclosure in any way.
The concentrations in the following examples are all final concentrations.
Example 1: synthesis of 50nm and 100nm spherical nano gold
1) Preparation of seeds
Weighing a certain amount of sodium citrate trihydrate, dissolving the sodium citrate trihydrate in 150mL of first-grade water to prepare 2.2mmol/L, and adding HAuCl4(concentration 25mmol/L) the solution was stirred vigorously in a water bath at 110 ℃ for 15 min. The color of the solution was observed to change from yellow to blue-gray, then to pink within 10min, to wine-red in about 30 min.
2) Preparation of growth solution
53mL of primary water, 2mL of sodium citrate (60mmol/L) and HAuCl were taken4Preparing solution from (25mmol/L), heating to 90 deg.C, cooling to 90 deg.C, and making into seed solution55mL of the solution was taken out and mixed with the reaction solution, and the mixture was reacted in a water bath at 95 ℃ for a certain period of time. The size of the nano gold particles is increased along with the increase of the size of the nano gold particles, and spherical nano gold with the particle size of 50nm and 100nm can be formed.
Example 2: synthesis of 50nm and 100nm cubic nanogold
1) Preparation of 50nm cubic seeds
First, HAuCl is added4(0.01mol/L) solution and cetyltrimethylammonium bromide were added to 10mL of primary water and shaken well for 5min, and the color of the solution was observed to change from light yellow to orange. Then adding the prepared NaBH at 25 DEG C4(0.1mol/L) solution. Upon addition, the color of the solution was observed to change from orange to brown immediately.
2) Preparation of 50nm cubic growth solution
HAuCl was added to the aqueous cetyl trimethyl ammonium bromide solution at room temperature4(0.01 mol/L). Then, a freshly prepared aqueous solution of ascorbic acid (0.1mol/L) was added to the mixture solution, the color of the solution immediately changed from orange to colorless, and the prepared seeds were dropped into the colorless liquid using a 5. mu.L micro syringe, reacted for 12 to 14 hours, and the solution was seen to appear deep red.
3) Preparation of 100nm cubic seed ①
0.25mL of HAuCl4(0.01mol/L) of the aqueous solution was added to a mixed solution of cetyltrimethylammonium bromide (0.1 mol/L). Shaking for several minutes, adding ice water to prepare NaBH4(0.1mol/L) aqueous solution, and then stirred at 28 ℃ for 1h in the absence of light.
4) Preparation of 100nm cubic seed ②
The above gold seeds were diluted 10-fold and added to a solution containing 6mL of 0.1mol/L ascorbic acid, cetyltrimethylammonium bromide (0.1mmol/L) and HAuCl4The growth was continued for 1h (0.01 mol/L).
5) Preparation of 100nm cubic growth solution
Seed ② was added to a solution containing cetyltrimethylammonium bromide, HAuCl4(0.01mol/L) and ascorbic acid (0.1mol/L), the total volume of the solution was 10 mL. And reacting for 12-14h in the dark.
Example 3: synthesis of 50nm and 100nm star shaped nano gold
1) Preparation of seeds
Adding HAuCl4(0.01mol/L) and trisodium citrate (0.02mol/L) were added to the primary water, and the total volume of the mixed solution was 20 mL. Then adding 60 mu L of ice water prepared sodium borohydride NaBH under stirring4Solution (0.1 mol/L). Adding NaBH4The solution turns pink immediately after the reaction, and gold spherical seeds are formed after the reaction for 2 hours in a dark place.
2) Preparation of growth solution
Cetyl trimethyl ammonium bromide is weighed and dissolved in 9.5mL of primary water, and HAuCl is added4(0.01 mol/L). The solution changed from yellow to orange. First adding AgNO under the condition of violent stirring3(0.01mol/L), and ascorbic acid (0.1mol/L) is then added. The orange solution turned into a clear colorless solution. Then, a certain amount of the seed solution is added into the colorless solution for reaction for a certain time.
Example 4: synthesis of 50nm and 100nm rod-like nanogold
1) Preparation of 50nm Bar-shaped seeds
Cetyl trimethyl ammonium bromide solution (0.1mol/L) and 0.01mol/L HAuCl4And (4) mixing. Adding ice water prepared 0.01mol/L NaBH into the stirred solution4The solution formed a brownish yellow solution and vigorous stirring of the seed solution was continued. The reaction was maintained at 25 ℃ for 2 h.
2) Preparation of 50nm rod-like growth solution
Temperature maintenanceHAuCl was added constantly to a solution of cetyltrimethylammonium bromide (0.1mol/L) at 29 deg.C4(0.01mol/L), mixing thoroughly, adding AgNO3(0.004mol/L) solution. Then, ascorbic acid (0.0788mol/L) solution was added as a mild reducing agent. The growth solution changed from dark yellow to colorless. mu.L of the seed solution was added to the growth solution. The color of the solution is gradually changed within 10-20 minutes, and the rod-shaped nano gold with the particle size of 50nm is obtained after the reaction for a certain time.
3) Preparation of 100nm Bar seed ①
Cetyl trimethyl ammonium bromide solution (0.1mol/L) and 0.01mol/L HAuCl4And (4) mixing. Adding ice water prepared 0.01mol/L NaBH into the stirred solution4The solution formed a brownish yellow solution and vigorous stirring of the seed solution was continued. The reaction was maintained at 25 ℃ for 2 h.
4) Preparation of 100nm gold stick seed ②
The temperature was kept constant at 29 ℃ by adding HAuCl to a solution of cetyltrimethylammonium bromide (0.1mol/L)4(0.01mol/L), mixing thoroughly, adding AgNO3(0.004mol/L) solution, ascorbic acid (0.0788mol/L) solution as a mild reducing agent was then added, the solution turned colorless from dark yellow, 12. mu.L of seed ① solution was added to the colorless solution, after a certain time of reaction, gold nanorod solution (10mL) was centrifuged at 8000rpm × 30 minutes to remove excess silver salt, ascorbic acid and HCl in the growth solution, and redispersed in 2mL of cetyltrimethylammonium bromide solution (0.1mol/L) so that the concentration of gold nanorods was 2.5mmol/L, yielding a seed ② solution for further growth.
5) Preparation of 100nm rod-shaped growth solution
In AgNO3Secondary growth of gold nanorods in the presence of a solution of cetyltrimethylammonium bromide (0.1mol/L) and HAuCl in a total volume of 10mL4(0.01mol/L) mixing to fully complex gold salt, and then adding AgNO3(0.004mol/L) and ascorbic acid (0.1 mol/L). finally, a solution of gold nanorod seeds ② is added.
Example 5: synthesis of 50nm and 100nm dumbbell-shaped nanogold
1) Preparation of dumbbell seed solution ①
Cetyl trimethyl ammonium bromide solution (0.1mol/L) and 0.01mol/L HAuCl4And (4) mixing. Adding ice water prepared 0.01mol/L NaBH into the stirred solution4The solution formed a brown-yellow solution and continued to stir vigorously. The reaction was maintained at 25 ℃ for 2 h.
2) Preparation of dumbbell seed solution ②
The temperature was kept constant at 29 ℃ and HAuCl was added to a solution of cetyltrimethylammonium bromide (0.1mol/L)4(0.01mol/L), mixing thoroughly, adding AgNO3(0.004mol/L) solution, ascorbic acid (0.0788mol/L) as a mild reducing agent was then added, the growth solution turned from dark yellow to colorless, 12. mu.L of a seed ① solution was added to the above solution, and the seed solution ② was obtained by reaction.
3) Preparation of dumbbell growth liquid
Cetyl trimethyl ammonium bromide (0.1mol/L) was mixed with HAuCl4(0.01mol/L) are fully mixed to form complex gold salt, then certain amount of KI (0.01mol/L) and ascorbic acid (0.1mol/L) are added, finally, solutions of seeds ② with different volumes are added, and the gold nanorods are secondarily grown into dumbbell-shaped nanogold with the size of 50nm and 100nm in the presence of KI.
Example 6: synthesis of 50nm and 100nm biconical nano-gold
1) Preparation of seeds
Adding HAuCl4(0.01mol/L) was mixed with an aqueous solution of cetyltrimethylammonium bromide (0.1 mol/L). Adding freshly prepared NaBH4(0.1mol/L) an ice-water solution. The solution changed from orange to brown indicating seed particle formation. Washing the seed solution in the dark at 40 deg.C for one week. The synthesis of bipyramid nanogold cannot be achieved using freshly prepared seeds, which need to be aged for at least 7 days.
2) Preparation of growth solution
Adding HAuCl4(0.01mol/L) was added to an aqueous solution of cetyltrimethylammonium bromide (0.1 mol/L). AgNO added with stirring3(4mmol/L) followed by hydroquinone (60mmol/L) and the appropriate volume of seed solution. Protected from light and water bath at 40 ℃ for 12 h.
Example 7: cytotoxicity
The twelve kinds of gold nanoparticles described in this example were synthesized by adjusting the amount of various additives using a seed growth method, the particle sizes were respectively concentrated at 50nm and 100nm, and the gold nanoparticles described in this example had good stability and biocompatibility, and the toxicity of the gold nanoparticles described in this invention on human hepatoma cells (HepG2) and normal hepatocytes (L02) was determined using the MTT method.
Example 8: 100nm bipyramid nanogold tumor photothermal therapy
Injecting 200 mu L PBS solution containing 100nm bipyramid nanogold 200 microgram into tumor-bearing mice inoculated with 4T1 mouse breast cancer cells at 500mW/cm in right hind limb through tail vein2Under the continuous irradiation of laser with the power of 808nm, a thermal imaging camera shoots a whole body imaging picture of the mouse, referring to the attached figure 12 of the specification, and the temperature of the tumor part of the tumor-bearing mouse reaches 65 ℃ after the laser irradiation is carried out for 10 minutes. Tumor size was monitored over a long period of time and mice were found to have completely disappeared tumors after laser irradiation. The material of the invention has better application prospect in the aspect of tumor photothermal treatment.
Example 9: photoacoustic imaging of 100nm cubic nanogold for tumors
50 mu L of PBS solution containing 50 mu g of cubic nanogold with the length of 100nm is injected into tumor-bearing mice with breast cancer cells of 4T1 mice inoculated on the right hind limb through tumor injection, a Vevo LAZR small animal photoacoustic imaging system is adopted to shoot an imaging picture of tumor parts of the mice, see the attached figure 13 of the specification, and the tumor parts of the mice show obvious photoacoustic signals after the nanogold is injected. The material of the invention has better application prospect in the aspect of tumor photoacoustic imaging.
Claims (6)
1. A method for preparing gold nanoparticles with controllable shape and size is characterized by comprising the following steps:
(1) preparation of seed solution: dissolving a proper amount of stabilizer in deionized water, adding chloroauric acid, stirring uniformly, then adding a sodium borohydride solution prepared by ice water or adopting a thermal reduction mode to form a brown yellow or red solution, and keeping the temperature of 25-110 ℃ for reaction;
(2) preparation of growth solution: a. dissolving a certain amount of stabilizer in deionized water, mixing with chloroauric acid solution, and changing the solution from dark yellow to colorless;
or,
a', dissolving a certain amount of stabilizer in deionized water, mixing with chloroauric acid solution, and then adding a structure directing agent, a pH regulator and a reducing agent to change the solution from dark yellow to colorless;
(3) mixing the seed solution obtained in the step (1) with the growth solution obtained in the step (2), and reacting in a water bath at 29-95 ℃;
or,
mixing the seed solution obtained in the step (1) with the growth solution obtained in the step (2) to prepare a new seed solution, mixing the new seed solution with the growth solution obtained in the step (2), and keeping the new seed solution in a water bath at 29-95 ℃ for reaction;
(4) and after the reaction is finished, collecting, centrifuging and purifying to obtain the nano gold particles.
2. The method for preparing gold nanoparticles with controllable shape and size according to claim 1, wherein the stabilizer in step (1) and step (2) is cetyl trimethyl ammonium bromide or sodium citrate; the structure directing agent in the step (2) is silver nitrate or potassium iodide, the pH regulator is hydrochloric acid, and the reducing agent is ascorbic acid or hydroquinone.
3. The method of claim 2, wherein the final concentration of chloroauric acid is 0.01 to 0.025mol/L, the final concentration of sodium borohydride is 0.01 to 0.1mol/L, the final concentration of cetyltrimethylammonium bromide is 0.0001 to 0.1mol/L, the final concentration of silver nitrate is 0.004 to 0.01mol/L, the final concentration of potassium iodide is 0.01 to 0.1mol/L, the final concentration of hydroquinone is 0.01 to 0.06mol/L, the final concentration of ascorbic acid is 0.01 to 0.1mol/L, the final concentration of sodium citrate is 0.0022 to 0.02mol/L, and the final concentration of hydrochloric acid is 0.5 to 1.5 mol/L.
4. The method for preparing gold nanoparticles with controllable shape and size according to claim 1, wherein the optimal seed reaction time in step (1) is 1-4h, and the optimal growth reaction time in step (3) is 12-16 h.
5. The gold nanoparticles obtained by the preparation method according to any one of claims 1 to 4, wherein the gold nanoparticles have any one of a spherical shape, a cubic shape, a star shape, a rod shape, a dumbbell shape and a biconical shape, and have a particle diameter of 50nm or 100 nm.
6. Use of the gold nanoparticles of claim 5 for the preparation of a medicament for tumor photothermal therapy or tumor photoacoustic imaging.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811482468.3A CN109396457B (en) | 2018-12-05 | 2018-12-05 | Shape and size controllable gold nanoparticle and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811482468.3A CN109396457B (en) | 2018-12-05 | 2018-12-05 | Shape and size controllable gold nanoparticle and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109396457A true CN109396457A (en) | 2019-03-01 |
CN109396457B CN109396457B (en) | 2022-02-15 |
Family
ID=65457368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811482468.3A Active CN109396457B (en) | 2018-12-05 | 2018-12-05 | Shape and size controllable gold nanoparticle and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109396457B (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110039067A (en) * | 2019-05-10 | 2019-07-23 | 江苏师范大学 | A kind of preparation of electropositive gold nano seed and its application in carcinomebryonic antigen detection |
CN110193608A (en) * | 2019-06-06 | 2019-09-03 | 中国科学院合肥物质科学研究院 | A kind of regulation method slave gold nano dumbbell to gold nano grain based on micro etch |
CN110280780A (en) * | 2019-07-28 | 2019-09-27 | 长春黄金研究院烟台贵金属材料研究所有限公司 | A kind of nano gold sol preparation method based on molten gold |
CN110455770A (en) * | 2019-08-12 | 2019-11-15 | 深圳市人民医院 | A kind of surface enhanced Raman scattering substrate and its preparation method and application |
CN111085692A (en) * | 2019-12-27 | 2020-05-01 | 季华实验室 | Irregular alloy nano material synthesis method based on high-temperature water phase reaction |
CN111535022A (en) * | 2020-04-07 | 2020-08-14 | 西安工程大学 | Preparation method of gold @ fiber flexible SERS substrate with simulated grain ear structure |
CN111535023A (en) * | 2020-04-16 | 2020-08-14 | 西安工程大学 | Preparation method of conductive nanofiber membrane |
CN111659903A (en) * | 2020-07-14 | 2020-09-15 | 国家纳米科学中心 | Gold nanorod and preparation method thereof |
CN111939275A (en) * | 2020-07-28 | 2020-11-17 | 同济大学 | Bimodal contrast agent, preparation method and application thereof |
CN113425851A (en) * | 2021-07-09 | 2021-09-24 | 南京市儿童医院 | Preparation method and application of BIX-01294 modified gold nano-star |
CN113433111A (en) * | 2021-06-25 | 2021-09-24 | 辽宁大学 | Liposome-based core-shell material for Raman spectrum detection and preparation method and application thereof |
CN113770372A (en) * | 2021-09-13 | 2021-12-10 | 中红外激光研究院(江苏)有限公司 | Preparation method of gold nanoparticle aggregate material |
CN115466602A (en) * | 2022-10-20 | 2022-12-13 | 西南大学 | AuNSs in-situ synthesis and application method based on seed-mediated method and portable thermometer |
US20230405675A1 (en) * | 2022-06-15 | 2023-12-21 | Industry-University Cooperation Foundation Hanyang University Erica Campus | Method for preparing gold nanorods using reducing agent mixture and reducing agent mixture for same |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101618461A (en) * | 2009-08-12 | 2010-01-06 | 吉林大学 | Preparation method of calabash-shaped, dumbbell-shaped or bar-shaped gold nano-particles |
US20120235095A1 (en) * | 2011-03-18 | 2012-09-20 | Leonid Vigderman | High-yield synthesis of gold nanorods with optical absorption at wavelengths greater than 1000nm using hydroquinone |
CN103243391A (en) * | 2013-05-02 | 2013-08-14 | 西安交通大学 | Method for preparing gold nanorods through induction of hydrogen peroxide under alkaline condition |
CN103394704A (en) * | 2013-08-20 | 2013-11-20 | 纳米籽有限公司 | Method for preparing high-purity gold nanoparticle bipyramid and composite nanomaterial of gold nanoparticle bipyramid |
KR20150096187A (en) * | 2014-02-14 | 2015-08-24 | 서울대학교산학협력단 | method of manufacturing nanoparticles using seed growth |
CN105499598A (en) * | 2015-12-10 | 2016-04-20 | 上海交通大学 | Preparation method for gold nano-rods |
CN105834451A (en) * | 2016-05-25 | 2016-08-10 | 东华大学 | Preparation method for gold nanoparticle bipyramids |
US20160256930A1 (en) * | 2015-03-02 | 2016-09-08 | Polyvalor, Société En Commandite | Alloy nanoparticles, process for their preparation and use thereof |
CN106077705A (en) * | 2016-08-19 | 2016-11-09 | 东华大学 | A kind of preparation method of gold nanorods |
-
2018
- 2018-12-05 CN CN201811482468.3A patent/CN109396457B/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101618461A (en) * | 2009-08-12 | 2010-01-06 | 吉林大学 | Preparation method of calabash-shaped, dumbbell-shaped or bar-shaped gold nano-particles |
US20120235095A1 (en) * | 2011-03-18 | 2012-09-20 | Leonid Vigderman | High-yield synthesis of gold nanorods with optical absorption at wavelengths greater than 1000nm using hydroquinone |
CN103243391A (en) * | 2013-05-02 | 2013-08-14 | 西安交通大学 | Method for preparing gold nanorods through induction of hydrogen peroxide under alkaline condition |
CN103394704A (en) * | 2013-08-20 | 2013-11-20 | 纳米籽有限公司 | Method for preparing high-purity gold nanoparticle bipyramid and composite nanomaterial of gold nanoparticle bipyramid |
KR20150096187A (en) * | 2014-02-14 | 2015-08-24 | 서울대학교산학협력단 | method of manufacturing nanoparticles using seed growth |
US20160256930A1 (en) * | 2015-03-02 | 2016-09-08 | Polyvalor, Société En Commandite | Alloy nanoparticles, process for their preparation and use thereof |
CN105499598A (en) * | 2015-12-10 | 2016-04-20 | 上海交通大学 | Preparation method for gold nano-rods |
CN105834451A (en) * | 2016-05-25 | 2016-08-10 | 东华大学 | Preparation method for gold nanoparticle bipyramids |
CN106077705A (en) * | 2016-08-19 | 2016-11-09 | 东华大学 | A kind of preparation method of gold nanorods |
Non-Patent Citations (1)
Title |
---|
HYO-YONG AHN等: "Extended gold nano-morphology diagram: synthesis of rhombic dodecahedra using CTAB and ascorbic acid", 《JOURNAL OF MATERIALS CHEMISTRY C》 * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110039067A (en) * | 2019-05-10 | 2019-07-23 | 江苏师范大学 | A kind of preparation of electropositive gold nano seed and its application in carcinomebryonic antigen detection |
CN110193608A (en) * | 2019-06-06 | 2019-09-03 | 中国科学院合肥物质科学研究院 | A kind of regulation method slave gold nano dumbbell to gold nano grain based on micro etch |
CN110280780A (en) * | 2019-07-28 | 2019-09-27 | 长春黄金研究院烟台贵金属材料研究所有限公司 | A kind of nano gold sol preparation method based on molten gold |
CN110455770A (en) * | 2019-08-12 | 2019-11-15 | 深圳市人民医院 | A kind of surface enhanced Raman scattering substrate and its preparation method and application |
CN111085692A (en) * | 2019-12-27 | 2020-05-01 | 季华实验室 | Irregular alloy nano material synthesis method based on high-temperature water phase reaction |
CN111535022A (en) * | 2020-04-07 | 2020-08-14 | 西安工程大学 | Preparation method of gold @ fiber flexible SERS substrate with simulated grain ear structure |
CN111535022B (en) * | 2020-04-07 | 2023-02-28 | 西安工程大学 | Preparation method of gold @ fiber flexible SERS substrate with simulated grain ear structure |
CN111535023B (en) * | 2020-04-16 | 2022-07-05 | 西安工程大学 | Preparation method of conductive nanofiber membrane |
CN111535023A (en) * | 2020-04-16 | 2020-08-14 | 西安工程大学 | Preparation method of conductive nanofiber membrane |
CN111659903A (en) * | 2020-07-14 | 2020-09-15 | 国家纳米科学中心 | Gold nanorod and preparation method thereof |
CN111939275A (en) * | 2020-07-28 | 2020-11-17 | 同济大学 | Bimodal contrast agent, preparation method and application thereof |
CN111939275B (en) * | 2020-07-28 | 2022-10-25 | 同济大学 | Bimodal contrast agent, preparation method and application thereof |
CN113433111A (en) * | 2021-06-25 | 2021-09-24 | 辽宁大学 | Liposome-based core-shell material for Raman spectrum detection and preparation method and application thereof |
CN113425851B (en) * | 2021-07-09 | 2021-12-17 | 南京市儿童医院 | Preparation method and application of BIX-01294 modified gold nano-star |
CN113425851A (en) * | 2021-07-09 | 2021-09-24 | 南京市儿童医院 | Preparation method and application of BIX-01294 modified gold nano-star |
CN113770372A (en) * | 2021-09-13 | 2021-12-10 | 中红外激光研究院(江苏)有限公司 | Preparation method of gold nanoparticle aggregate material |
US20230405675A1 (en) * | 2022-06-15 | 2023-12-21 | Industry-University Cooperation Foundation Hanyang University Erica Campus | Method for preparing gold nanorods using reducing agent mixture and reducing agent mixture for same |
CN115466602A (en) * | 2022-10-20 | 2022-12-13 | 西南大学 | AuNSs in-situ synthesis and application method based on seed-mediated method and portable thermometer |
Also Published As
Publication number | Publication date |
---|---|
CN109396457B (en) | 2022-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109396457B (en) | Shape and size controllable gold nanoparticle and preparation method and application thereof | |
Zhang et al. | Tumor environment responsive degradable CuS@ mSiO2@ MnO2/DOX for MRI guided synergistic chemo-photothermal therapy and chemodynamic therapy | |
Wang | Synthetic methods of CuS nanoparticles and their applications for imaging and cancer therapy | |
Xia et al. | Preparation of gold nanorods and their applications in photothermal therapy | |
Xu et al. | High-yield synthesis of gold bipyramids for in vivo CT imaging and photothermal cancer therapy with enhanced thermal stability | |
Hamrayev et al. | Preparation of zinc oxide nanoparticles and its cancer treatment effects: A review paper | |
Lin et al. | Near-infrared light activated delivery platform for cancer therapy | |
Liu et al. | Photothermal therapy of Lewis lung carcinoma in mice using gold nanoshells on carboxylated polystyrene spheres | |
KR100873176B1 (en) | Sythesis of Gold Nanoparticles of Various Crystal Shapes Using Halide Ion | |
CN106141201A (en) | A kind of method improving gold nanorods light thermal property and photo and thermal stability | |
CN105251420A (en) | Preparation method for multifunctional composite microspheres | |
Liu et al. | Gold-nanobranched-shell based drug vehicles with ultrahigh photothermal efficiency for chemo-photothermal therapy | |
CN106729738A (en) | A kind of dendritic golden platinum bimetal nano particles and its preparation method and application | |
Lee et al. | Application of plasmonic gold nanoparticle for drug delivery system | |
CN112370526A (en) | Synthesis method of gold nanorods for photothermal therapy of cancer | |
Shevtsov et al. | Recent advances in gold nanoformulations for cancer therapy | |
Kim et al. | Synthesis of gold nanorod-embedded polymeric nanoparticles by a nanoprecipitation method for use as photothermal agents | |
CN108904471B (en) | Nano drug carrier Au/MnO2And preparation method and application thereof | |
CN105833270A (en) | Preparation method of nanometer metal particles and preparation method of nanometer probe | |
CN112156192A (en) | Composite nano probe with targeted fluorescence/magnetic resonance bimodal imaging and photothermal therapy functions and preparation and application thereof | |
Fang et al. | Multifunctional nanotheranostic gold nanocage/selenium core-shell for PAI-guided chemo-photothermal synergistic therapy in vivo | |
Yu et al. | Self-assembly synthesis of flower-like gold nanoparticles for photothermal treatment of cancer | |
Fu et al. | High-yield preparation of robust gold nanoshells on silica nanorattles with good biocompatiblity | |
Alshangiti et al. | The energetic and physical concept of gold nanorod-dependent fluorescence in cancer treatment and development of new photonic compounds| review | |
CN108723386A (en) | A kind of preparation method of the gold nano dendrite particle with photo-thermal effect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |